These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8174907)

  • 21. Omeprazole in infants with cimetidine-resistant peptic esophagitis.
    Alliët P; Raes M; Bruneel E; Gillis P
    J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The omeprazole treatment of patients with diseases of the upper digestive tract].
    Degtiareva II; Zukheĭr Kh; Lodianaia EV; Palladina OL; Nevstruev VP; Piletskiĭ AM; Chervak IN
    Lik Sprava; 1994; (7-8):117-20. PubMed ID: 7900331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Short-term intervention in ulcer and reflux. New acid blocker halves duration of therapy].
    Einecke D
    MMW Fortschr Med; 2000 Jul; 142(26-27):50-1. PubMed ID: 10929487
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety experience from long-term treatment with omeprazole.
    Joelson S; Joelson IB; Lundborg P; Walan A; Wallander MA
    Digestion; 1992; 51 Suppl 1():93-101. PubMed ID: 1397750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemolytic anemia associated with the use of omeprazole.
    Marks DR; Joy JV; Bonheim NA
    Am J Gastroenterol; 1991 Feb; 86(2):217-8. PubMed ID: 1992636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB; Faulds D; McTavish D
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose omeprazole for erosive esophagitis.
    Epling J; Taylor H
    J Fam Pract; 1999 Feb; 48(2):93-4. PubMed ID: 10037536
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

  • 31. [Substituted benzimidazoles--a new dimension in ulcer therapy?].
    Fimmel CJ; Blum AL
    Wien Klin Wochenschr; 1984 Feb; 96(4):149-53. PubMed ID: 6324498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reduced ex vivo production of superoxide anion by polymorphonuclear leukocytes during therapy with omeprazole. A pharmacological effect?].
    Capodicasa E; Ciaccio V; Corazzi F; De Bellis F; Bucaneve G; Ficola F; Pelli MA
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):105-11. PubMed ID: 7948319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?].
    Müller-Lissner S
    Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391
    [No Abstract]   [Full Text] [Related]  

  • 34. [Omeprazole and maintenance treatment: new concepts for traditional therapies?].
    Díaz de Rojas F; Ponce García J
    An Med Interna; 1992 Sep; 9(9):450-4. PubMed ID: 1391583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk for developing tumors in therapy with the proton pump inhibitor omeprazole].
    Eissele R; Arnold R
    Versicherungsmedizin; 1993 Aug; 45(4):126-9. PubMed ID: 8379045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Omeprazole is more cost-effective than ranitidine in reflux esophagitis].
    Lindberg G; Jönsson B
    Lakartidningen; 1992 Jul; 89(30-31):2530-3. PubMed ID: 1507987
    [No Abstract]   [Full Text] [Related]  

  • 37. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U; Holtermüller KH
    Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
    [No Abstract]   [Full Text] [Related]  

  • 38. Omeprazole.
    BMJ; 1991 Oct; 303(6806):850-1. PubMed ID: 1932982
    [No Abstract]   [Full Text] [Related]  

  • 39. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.